Oisinbio
Biotechnology · Prescription Drugs
Overview
Oisín Biotechnologies develops genetic medicines to address age-related diseases.
Funding and backers
Backers
1
Healthspan Capital
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Highlights. Vincere makes new medicines to treat age-related diseases including Parkinson's and Kidney disease.
We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent…
Transforming Eye Care With Precision Medicine. Age-related macular degeneration (AMD) impacts one in eight people over the age of fifty and…
Advancing medicines to restore homeostasis. Cajal Therapeutics is developing novel medicines for serious diseases, including anemias of…
General Control Biotechnologies pioneers durable, reversible multi-gene epigenetic therapies to combat the complexities of age-related…
Himuka AM Pharma develops drug candidates derived from adrenomedullin (AM), a bioactive peptide originally discovered at the University of…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Healthspan CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely